The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Prediction of acute myeloid leukaemia risk in healthy individuals
Open accessAbstract
The incidence of acute myeloid leukaemia (AML) increases with age and mortality exceeds 90% when diagnosed after age 65. Most cases arise without any detectable early symptoms and patients usually present with the acute complications of bone marrow failure 1. The onset of such de novo AML cases is typically preceded by the accumulation of somatic mutations in preleukaemic haematopoietic stem and progenitor cells (HSPCs) that undergo clonal expansion 2,3. However, recurrent AML mutations also accumulate in HSPCs during ageing of healthy individuals who do not develop AML, a phenomenon referred to as age-related clonal haematopoiesis (ARCH)4-8. Here we use deep sequencing to analyse genes that are recurrently mutated in AML to distinguish between individuals who have a high risk of developing AML and those with benign ARCH. We analysed peripheral blood cells from 95 individuals that were obtained on average 6.3 years before AML diagnosis (pre-AML group), together with 414 unselected age- and gender-matched individuals (control group). Pre-AML cases were distinct from controls and had more mutations per sample, higher variant allele frequencies, indicating greater clonal expansion, and showed enrichment of mutations in specific genes. Genetic parameters were used to derive a model that accurately predicted AML-free survival; this model was validated in an independent cohort of 29 pre-AML cases and 262 controls. Because AML is rare, we also developed an AML predictive model using a large electronic health record database that identified individuals at greater risk. Collectively our findings provide proof-of-concept that it is possible to discriminate ARCH from pre-AML many years before malignant transformation. This could in future enable earlier detection and monitoring, and may help to inform intervention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, progression to hematological malignancies depends on the type and complexity of mutations in CHIP.2,5,6”
From Aging drives Tet2 +/− clonal hematopoiesis via IL-1 signaling (2023) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“CH-associated variants of the epigenetic writers and erasers Dnmt3a and Tet2, respectively, that affect the HSPC methylome have been shown to alter functions of monocyte-derived tissue M F and promote cardiovascular pathologies 31-34 .”
From Clonal hematopoiesis-associated motoric deficits caused by monocyte-derived microglia accumulating in aging mice (2025) · cites this paper as [34]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“CH prominently involves variants of epigenetic regulatory genes, such as DNMT3A and TET2, which constitute an increased risk for hematologic malignancies, cardiovascular events and stroke 34,45,70,71 .”
From Clonal hematopoiesis-associated motoric deficits caused by monocyte-derived microglia accumulating in aging mice (2025) · cites this paper as [34]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Clone size, which is approximated by the variant allele fraction (VAF), has previously been shown to be an important predictor of risk for blood cancer1,17 and cardiovascular outcomes8,9.”
From Clonal hematopoiesis is associated with protection from Alzheimer’s disease (2023) · cites this paper as [17]
The cited source says what the claim attributes to it.
In the citing paper
“CH prominently involves variants of epigenetic regulatory genes, such as DNMT3A and TET2, which constitute an increased risk for hematologic malignancies, cardiovascular events and stroke 34,45,70,71 .”
From Clonal hematopoiesis-associated motoric deficits caused by monocyte-derived microglia accumulating in aging mice (2025) · cites this paper as [34]
In the citing paper
“Both groups found that individuals with antecedent clonal hematopoiesis were at ~3 to 5-fold increased risk for developing AML in the subsequent years (Fig. 3A).”
From Clonal hematopoiesis in human aging and disease (2019) · cites this paper as [71]
In the citing paper
“The effect of specific gene variants on various outcomes may be quite different, as has been found in AML 71.”
From Clonal hematopoiesis in human aging and disease (2019) · cites this paper as [71]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
McKenna, A., Hanna, M., Banks, E., Sivachenko, A., Cibulskis, K., Kernytsky, A., Garimella, K., Altshuler, D., Gabriel, S., Daly, M., et al. (2010) · Genome Research · doi:10.1101/gr.107524.110 · Cited by 27,895
BEDTools: a flexible suite of utilities for comparing genomic features
Quinlan, A. R., & Hall, I. M. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq033 · Cited by 27,437
Fast and accurate long-read alignment with Burrows-Wheeler transform.
Li, H., & Durbin, R. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp698 · Cited by 12,063
Arber, D. A., Orazi, A., Hasserjian, R., Thiele, J., Borowitz, M. J., Le Beau, M. M., Bloomfield, C. D., Cazzola, M., & Vardiman, J. W. (2016) · Blood · doi:10.1182/blood-2016-03-643544 · Cited by 10,119
Modeling Survival Data: Extending the Cox Model
Therneau, T. M., & Grambsch, P. M. (2000) · Statistics for Biology and Health · doi:10.1007/978-1-4757-3294-8 · Cited by 8,674
VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencingPreprint
Koboldt, D. C., Zhang, Q., Larson, D. E., Shen, D., McLellan, M. D., Lin, L., Miller, C. A., Mardis, E. R., Ding, L., & Wilson, R. K. (2012) · Genome Research · doi:10.1101/gr.129684.111 · Cited by 4,954
Age-related clonal hematopoiesis associated with adverse outcomes
Jaiswal, S., Fontanillas, P., Flannick, J., Manning, A., Grauman, P. V., Mar, B. G., Lindsley, R. C., Mermel, C. H., Burtt, N., Chavez, A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1408617 · Cited by 4,841
Genomic classification and prognosis in acute myeloid leukemia
Papaemmanuil, E., Gerstung, M., Bullinger, L., Gaidzik, V. I., Paschka, P., Roberts, N. D., Potter, N. E., Heuser, M., Thol, F., Bolli, N., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1516192 · Cited by 4,350
Self-citationClonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence
Genovese, G., Kähler, A. K., Handsaker, R. E., Lindberg, J., Rose, S. A., Bakhoum, S. F., Chambert, K., Mick, E., Neale, B. M., Fromer, M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1409405 · Cited by 3,531
Cited by
Sorted by citations
Items 401–500 of 847
Longitudinal dynamics of clonal hematopoiesis identifies gene-specific fitness effectsPreprint
Robertson, N., Crespo, E. L., Terradas-Terradas, M., Purcell, A. C., Livesey, B., Marsh, J. A., Murphy, L., Murphy, L., MacGillivray, L., MacGillivray, L., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1038/s41591-022-01 · Cited by 13
Game of clones: Diverse implications for clonal hematopoiesis in lymphoma and multiple myeloma
Meier, J., Jensen, J. L., Dittus, C. E., Coombs, C. C., & Rubinstein, S. M. (2022) · Blood Reviews · doi:10.1016/j.blre.2022.100986 · Cited by 15
Deepak Shyl, E. S., Beutline Malgija, M., Iniyan, A. M., Mahendran, R., & Vincent, S. G. P. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e11123 · Cited by 13
Targeted, Amplicon-Based, Next-Generation Sequencing to Detect Age-Related Clonal Hematopoiesis
Snetsinger, B., Ferrone, C. K., & Rauh, M. J. (2019) · Methods in molecular biology · doi:10.1007/7651_2019_216 · Cited by 13
Generating Proteomic Big Data for Precision Medicine
Yue, L., Zhang, F., Sun, R., Sun, Y., Yuan, C., Zhu, Y., & Guo, T. (2020) · PROTEOMICS · doi:10.1002/pmic.201900358 · Cited by 12
Wu, B., Song, F., Han, X., Zhao, M., Huang, M., Zhang, W., Tan, T., Gong, Y., Cao, C., & Cheng, S. (2025) · Annals of Medicine · doi:10.1080/07853890.2025.2557507 · Cited by 12
Cao, L., Wang, Z., Cui, Y., Li, Y., & Xiang, Q. (2025) · Biomarker Research · doi:10.1186/s40364-025-00839-2 · Cited by 12
Genomic analysis of cellular hierarchy in acute myeloid leukemia using ultrasensitive LC-FACSeq
Saygin, C., Hu, E. Y., Zhang, P., Sher, S., Lozanski, A., Doong, T.-J., Nicolet, D., Orwick, S. J., Labanowska, J. M., Skinner, J. N., et al. (2021) · Leukemia · doi:10.1038/s41375-021-01295-1 · Cited by 12
Kövy, P., Őrfi, Z., Bors, A., Kozma, A., Gopcsa, L., Dolgos, J., Lovas, N., Harasztdombi, J., Lakatos, V., Király, Á., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0253386 · Cited by 12
The genetic determinants of recurrent somatic mutations in 43,693 blood genomes
Weinstock, J. S., Laurie, C. A., Broome, J., Taylor, K. D., Guo, X., Shuldiner, A. R., O’Connell, J. R., Lewis, J. P., Boerwinkle, E., Barnes, K. C., et al. (2023) · Science Advances · doi:10.1126/sciadv.abm4945 · Cited by 11
Tan, M., Liu, B., You, R., Huang, Q., Lin, L., Cai, D., Yang, R., Li, D., & Huang, H. (2023) · International Journal of Medical Sciences · doi:10.7150/ijms.79619 · Cited by 12
Mammadova, J., Colin, C., Nguyen, D., Mhaskar, R. S., Ganesan, S., Tang, Y.-H., Teng, M., Ismail-Khan, R. R., & Gillis, N. (2023) · JCO Precision Oncology · doi:10.1200/po.23.00208 · Cited by 13
Tan, M., You, R., Cai, D., Wang, J., Dai, W., Yang, R., Li, D., & Huang, H. (2024) · International Journal of Medical Sciences · doi:10.7150/ijms.103125 · Cited by 13
Marrow failure and aging: The role of “Inflammaging”
Zhao, J., Ghimire, A., & Liesveld, J. L. (2021) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2021.101283 · Cited by 12
Huang, R., Liao, X., & Li, Q. (2022) · Mathematical Biosciences & Engineering · doi:10.3934/mbe.2022112 · Cited by 12
Spitzer, B. G., Rutherford, K. D., Gundem, G., McGovern, E. M., Millard, N. E., Ossa, J. A., Cheung, I. Y., Gao, T., Levine, M. F., Zhang, Y., et al. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-2451 · Cited by 12
Majeti, R., Jamieson, C. H. M., Pang, W. W., Jaiswal, S., Leeper, N. J., Wernig, G., & Weissman, I. L. (2022) · Annual Review of Medicine · doi:10.1146/annurev-med-042420-104436 · Cited by 12
Shabashvili, D. E., Feng, Y., Kaur, P., Venugopal, K., & Guryanova, O. A. (2022) · Experimental Hematology · doi:10.1016/j.exphem.2022.03.008 · Cited by 14
Osman, A. E. G., Mencia-Trinchant, N., Saygin, C., Moma, L., Kim, A., Housman, G., Pozsgai, M. J., Sinha, E., Chandra, P., Hassane, D. C., et al. (2022) · Blood Advances · doi:10.1182/bloodadvances.2022008521 · Cited by 11
Abelson, S., Zeng, A. G. X., Nofech-Mozes, I., Wang, T. T., Ng, S., Minden, M. D., Pugh, T. J., Awadalla, P., Shlush, L. I., Murphy, T., et al. (2020) · Science Advances · doi:10.1126/sciadv.abe3722 · Cited by 14
CDK4/6 inhibition mitigates chemotherapy-induced expansion of TP53-mutant clonal hematopoiesis
Chan, I. C. C., Zhang, P., Pan, X., Castro, C., Fox, N., Lewis, A. M., Weis, K., Cuibus, M. A., Tittley, S., Petrone, G. E. M., et al. (2026) · Nature Genetics · doi:10.1038/s41588-026-02526-w · Cited by 17
Werneth, C. M., Patel, Z. S., Thompson, M. S., Blattnig, S. R., & Huff, J. L. (2024) · Communications Medicine · doi:10.1038/s43856-023-00408-4 · Cited by 13
Clinical and Therapeutic Implications of Clonal Hematopoiesis
Petrone, G. E. M., Turker, I., Natarajan, P., & Bolton, K. L. (2024) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-120722-100409 · Cited by 11
Chow, R. D.-W., Velu, P., Deihimi, S., Belman, J., Youn, A., Shah, N., Luger, S. M., Carroll, M. P., Morrissette, J. J. D., & Bowman, R. L. (2025) · Blood Advances · doi:10.1182/bloodadvances.2024015149 · Cited by 12
Tan, H. S. V., Jiang, H., & Wang, S. S. Y. (2025) · Annals of Hematology · doi:10.1007/s00277-025-06244-x · Cited by 13
Yang, Y., Cathelin, S., Liu, A. C. H., Subedi, A., Maher, A., Hosseini, M., Ayyathan, D. M., Vanner, R. J., & Chan, S. M. (2025) · Nature Communications · doi:10.1038/s41467-025-57614-y · Cited by 12
Bahmani, F., Shayanmanesh, M., Safari, M., Alaei, A., Pouriafar, Y., Rasti, Z., Zaker, F., Rostami, S., Damerchiloo, F., & Safa, M. (2025) · Cancer Cell International · doi:10.1186/s12935-025-03793-z · Cited by 12
Modelling the ageing dependence of cancer evolutionary trajectories
Henry, C. J., & DeGregori, J. V. (2025) · Nature reviews. Cancer · doi:10.1038/s41568-025-00838-3 · Cited by 14
Leukemia Stem Cells in the Pathogenesis, Progression, and Treatment of Acute Myeloid Leukemia
Joshi, K., Zhang, L., Breslin, P., & Zhang, J. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-7342-8_5 · Cited by 14
Reference intervals of red blood cell parameters and platelet count for healthy adults in Japan
Takami, A., Watanabe, S., Yamamoto, Y., Kondo, H., Bamba, Y., Ohata, M., Mishima, S., Kubota, H., Nishiura, A., Miura, R., et al. (2021) · International Journal of Hematology · doi:10.1007/s12185-021-03166-y · Cited by 11
Enriched clonal hematopoiesis in seniors with dietary vitamin C inadequacy
Chen, J., Nie, D., Wang, X., Wang, L., Wang, F., Zhang, Y., Xue, C., Cao, P., Li, M., Ma, X., et al. (2021) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2021.10.014 · Cited by 11
Molecular Diagnostic Testing for Hematopoietic Neoplasms
Hergott, C. A., & Kim, A. S. (2022) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2022.04.005 · Cited by 11
Imran, H., An, J., Jang, K., Alam, A., Dharuman, V., Ko, M., & Lim, S. (2023) · Journal of Alloys and Compounds · doi:10.1016/j.jallcom.2023.169715 · Cited by 11
The significance of PA28γ and U2AF1 in oral mucosal carcinogenesis
Yin, F., Wang, J., Zhao, K., Xin, C., Shi, Y., Zeng, X. Y., Xu, H. Y., Li, J., & Chen, Q. (2019) · Oral Diseases · doi:10.1111/odi.13213 · Cited by 11
Bertuccio, S. N., Anselmi, L., Masetti, R., Lonetti, A., Cerasi, S., Polidori, S., Serravalle, S., & Pession, A. (2021) · Cancers · doi:10.3390/cancers13091995 · Cited by 11
Pseudo-mutant P53 is a unique phenotype of DNMT3A-mutated pre-leukemia
Tuval, A., Brilon, Y., Azogy, H., Moskovitz, Y., Biezuner, T., Leshkowitz, D., Salame, T. M., Minden, M. D., Tal, P., Rotter, V., et al. (2022) · Haematologica · doi:10.3324/haematol.2021.280329 · Cited by 12
Dhindsa, R. S., Burren, O. S., Sun, B. B., Prins, B. P., Matelska, D., Wheeler, E., Mitchell, J., Oerton, E., Hristova, V. A., Smith, K. R., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.10.09.511476 · Cited by 11
Jakobsen, N. A., Turkalj, S., Zeng, A. G. X., Stoilova, B., Metzner, M., Nagree, M. S., Shah, S., Moore, R., Usukhbayar, B., Salazar, M. A., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.09.12.557322 · Cited by 11
Metabolic reprogramming regulated by TRAF6 contributes to the leukemia progression
Matsui, S., Ri, C., Bolanos, L. C., Choi, K., Shibamiya, A., Ishii, A., Takaishi, K., Oshima‐Hasegawa, N., Tsukamoto, S., Takeda, Y., et al. (2024) · Leukemia · doi:10.1038/s41375-024-02245-3 · Cited by 10
Imran, H., Lee, H., Alam, A., An, J., Ko, M., & Lim, S. (2024) · Materials Today Bio · doi:10.1016/j.mtbio.2024.101123 · Cited by 10
Novel insights and therapeutic approaches in secondary AML
Marconi, G., Rondoni, M., Zannetti, B. A., Zacheo, I., Nappi, D., Mattei, A., Rocchi, S., & Lanza, F. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1400461 · Cited by 10
Understanding the impact of mitochondrial DNA mutations on aging and carcinogenesis (Review)
Kobayashi, H., & Imanaka, S. (2025) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2025.5559 · Cited by 11
Do next-generation sequencing results drive diagnostic and therapeutic decisions in MDS?
Thol, F. R., & Platzbecker, U. (2019) · Blood Advances · doi:10.1182/bloodadvances.2018022434 · Cited by 10
Xu, J., Šrám, R. J., Cebulska-Wasilewska, A., Miloradov, M. V., Şardaş, S., & Au, W. W. (2020) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2020.115011 · Cited by 10
The evolution of leukaemia from pre‐leukaemic and leukaemic stem cells
Shlush, L. I., & Feldman, T. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13236 · Cited by 10
Clonal haematopoiesis of emerging significance
Hammond, D. E., & Loghavi, S. (2021) · Pathology · doi:10.1016/j.pathol.2021.02.005 · Cited by 10
Clonal hematopoiesis and myeloid malignancies: clonal dynamics and clinical implications
Elena, C., Gallì, A., Bono, E. B., Todisco, G., & Malcovati, L. (2021) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000675 · Cited by 10
Clonal Hematopoiesis: Confluence of Malignant and Nonmalignant Diseases
Lin, A. E., Rauch, P. J., Jaiswal, S., & Ebert, B. L. (2022) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-060121-120026 · Cited by 8
Comparison of acute myeloid leukemia and myelodysplastic syndromes with TP53 aberrations
Dutta, S., Moritz, J. M., Pregartner, G., Thallinger, G., Brandstätter, I., LIND, K., Rezania, S., Lyssy, F., Reinisch, A., Zebisch, A., et al. (2022) · Annals of Hematology · doi:10.1007/s00277-022-04766-2 · Cited by 10
The hematopoietic saga of clonality in sickle cell disease
Stonestrom, A. J., & Levine, R. L. (2022) · Journal of Clinical Investigation · doi:10.1172/jci158251 · Cited by 10
Advances in understanding the molecular basis of clonal hematopoiesis
Alagpulinsa, D. A., Toribio, M. P., Alhallak, I., & Reis, R. J. S. (2022) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2022.03.002 · Cited by 11
Clinical Applications of Chromosomal Microarray Testing in Myeloid Malignancies
Ronaghy, A., Yang, R. K., Khoury, J. D., & Kanagal‐Shamanna, R. (2020) · Current Hematologic Malignancy Reports · doi:10.1007/s11899-020-00578-1 · Cited by 11
Pettersson, L., Chen, Y., George, A. M., Rigo, R., Lazarević, V., Juliusson, G., Saal, L. H., & Ehinger, M. (2020) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2020.1755855 · Cited by 10
Clonal haematopoiesis and cardiovascular disease: how low can you go?
Evans, M. A., Sano, S., & Walsh, K. X. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa848 · Cited by 10
Nam, A. S., Dusaj, N. N., Izzo, F., Murali, R., Myers, R. M., Mouhieddine, T. H., Sotelo, J., Benbarche, S., Waarts, M. R., Gaiti, F., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.01.14.476225 · Cited by 10
Myers, R. M., Izzo, F., Kottapalli, S., Prieto, T., Dunbar, A. J., Bowman, R. L., Mimitou, E. P., Stahl, M. F., Ghaity-Beckley, S. E., Arandela, J., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.05.11.491515 · Cited by 13
Telomere Length and Clonal Hematopoiesis
Vassiliou, G. S. (2023) · New England Journal of Medicine · doi:10.1056/nejme2303022 · Cited by 10
Evolutionary dynamics in the decades preceding acute myeloid leukaemiaPreprint
Watson, C. J., Poon, G. Y. P., MacGregor, H. A. J., Fonseca, A. V. A., Apostolidou, S., Gentry‐Maharaj, A., Menon, U., & Blundell, J. R. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.07.05.602251 · Cited by 12
Clonal hematopoiesis and bone marrow inflammation
Xie, X., Su, M., Ren, K., Ma, X., Lv, Z., Li, Z., Mei, Y., & Ji, P. (2022) · Translational research · doi:10.1016/j.trsl.2022.11.004 · Cited by 10
Clonal hematopoiesis in people with advanced HIV and associated inflammatory syndromes
Rocco, J. M., Zhou, Y., Liu, N., Laidlaw, E., Galindo, F., Anderson, M. V., Rupert, A. W., Lage, S. L., Ortega‐Villa, A. M., Yu, S. J., et al. (2024) · JCI Insight · doi:10.1172/jci.insight.174783 · Cited by 10
A Simple‐to‐Use Nomogram for Predicting Survival in Children with Acute Myeloid Leukemia
Jiang, F., Yu, X., Wu, C., Wang, M., Wei, K., Zhou, G., & Wang, J. (2021) · BioMed Research International · doi:10.1155/2021/7264623 · Cited by 9
Caprioli, C., Nazari, I., Milovanovic, S., & Pelicci, P. G. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2021.796477 · Cited by 9
Hussein, S. E., & Loghavi, S. (2022) · Cancers · doi:10.3390/cancers14225690 · Cited by 10
Microenvironmental control of hematopoietic stem cell fate via CXCL8 and protein kinase C
Binder, V., Li, W., Faisal, M. S., Oyman, K., Calkins, D. L., Shaffer, J. L., Teets, E. M., Sher, S., Magnotte, A., Belardo, A. M., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112528 · Cited by 11
IDH2 mutations in acute myeloid leukemia
Babakhanlou, R., Dinardo, C. D., & Borthakur, G. M. (2023) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2023.2237153 · Cited by 9
Gillis, N., Padron, E., Wang, T., Chen, K. S., DeVos, J. D., Spellman, S. R., Lee, S. J., Kitko, C. L., MacMillan, M. L., West, J., et al. (2023) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2023.07.021 · Cited by 9
A mosaic analysis system with Cre or Tomato expression in the mouse
Wang, Q., Lin, Y., Zhang, B., Wu, J., Roy, S., Ratiu, J. J., Xu, Y., Dai, M., Hale, L. P., Xiong, Y., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2014308117 · Cited by 9
High expression of HOXA5 is associated with poor prognosis in acute myeloid leukemia
Yang, Y. B., Zhong, F., Huang, X., Zhang, N., Du, J., Long, Z., Zheng, B., Lin, W., Liu, W., & Ma, W. (2020) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2020.100673 · Cited by 10
Heini, A. D., Porret, N. A., Zenhäusern, R., Winkler, A., Bacher, U., & Pabst, T. (2021) · Cancers · doi:10.3390/cancers13133190 · Cited by 9
Utility of plasma cell-free DNA for de novo detection and quantification of clonal hematopoiesis
Gutierrez‐Rodrigues, F., Beerman, I., Groarke, E. M., Patel, B. A., Spitofsky, N., Dillon, L. W., Raffo, D. Q., Hourigan, C. S., Kajigaya, S., Ferrucci, L., et al. (2021) · Haematologica · doi:10.3324/haematol.2021.279230 · Cited by 9
Energy oversupply to tissues: a single mechanism possibly underlying multiple cancer risk factors
Wu, D. J., Aktipis, A., & Pepper, J. W. (2019) · Evolution Medicine and Public Health · doi:10.1093/emph/eoz004 · Cited by 9
Using mathematical models to improve risk-scoring in acute myeloid leukemia
Stiehl, T. (2020) · Chaos An Interdisciplinary Journal of Nonlinear Science · doi:10.1063/5.0023830 · Cited by 9
The evolutionary dynamics and fitness landscape of clonal haematopoiesisPreprint
Watson, C. J., Papula, A., Poon, Y. P. G., Wong, W., Young, A. L., Druley, T. E., Fisher, D. S., & Blundell, J. R. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/569566 · Cited by 9
Gaiti, F., Chamely, P., Hawkins, A. G., Cortés-López, M., Swett, A. D., Ganesan, S., Mouhieddine, T. H., Dai, X., Kluegel, L., Chen, C. Y., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.08.495292 · Cited by 9
A tower of babel of acronyms? The shadowlands of MGUS/MBL/CHIP/TCUS
Bravo‐Pérez, C., & Gurnari, C. (2024) · Seminars in Hematology · doi:10.1053/j.seminhematol.2024.01.004 · Cited by 8
Implications of Clonal Hematopoiesis in Hematological and Non-Hematological Disorders
Zhang, Q., Yim, R., Lee, P., Chin, L., Li, V., & Gill, H. (2024) · Cancers · doi:10.3390/cancers16234118 · Cited by 10
Detecting and quantifying clonal selection in somatic stem cells
Körber, V., Jakobsen, N. A., Ansari‐Pour, N., Moore, R., Claudino, N., Metzner, M., Thielecke, E., Esau, F., Usukhbayar, B., Salazar, M. A., et al. (2025) · Nature Genetics · doi:10.1038/s41588-025-02217-y · Cited by 14
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC
Testa, U., Castelli, G., & Pelosi, E. (2022) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2022.069 · Cited by 9
Brett, V., Lechevalier, N., Trimoreau, F., Dussiau, C., Dimicoli, S., Coster, L., Luquet, I., Nadal, N., Ribourtout, B., Chapiro, É., et al. (2022) · Genes Chromosomes and Cancer · doi:10.1002/gcc.23107 · Cited by 8
Review of clonal hematopoiesis, subtypes and its role in neoplasia and different morbidities
Younes, I. E., Syler, L. B., & Hamed, A. (2023) · Leukemia Research · doi:10.1016/j.leukres.2023.107307 · Cited by 8
Analysis of Mean Corpuscular Volume and Red Cell Distribution Width in Patients with Aplastic Anemia
Liu, L., Fu, Q., Zhang, D., Chen, D., Wang, F., Guo, R., Xie, X., Jiang, Z., Yu, J., & Li, Y. (2023) · Hemoglobin · doi:10.1080/03630269.2023.2206575 · Cited by 8
Genetic Predisposition to Clonal Hematopoiesis
Quirós, P. M., & Vassiliou, G. S. (2023) · HemaSphere · doi:10.1097/hs9.0000000000000947 · Cited by 8
Silver, A. J., Vlasschaert, C., Mack, T., Sharber, B., Xu, Y., Bick, A. G., Pinson, C. W., & Savona, M. R. (2024) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-3840 · Cited by 8
Haque, T., Shastri, A., Desai, P. M., Xie, Z., Hammond, D. E., King, Z., Kishtagari, A., Madanat, Y. F., Abaza, Y., Silver, A. J., et al. (2024) · British Journal of Haematology · doi:10.1111/bjh.19925 · Cited by 8
Single-cell DNA sequencing reveals pervasive positive selection throughout preleukemic evolution
Poon, G. Y. P., Vedi, A., Sanders, M. A., Laurenti, E., Valk, P. J. M., & Blundell, J. R. (2025) · Cell Genomics · doi:10.1016/j.xgen.2024.100744 · Cited by 8
Enhancers and MYC interplay in hematopoiesis
Benetatos, L., Benetatou, A., & Vartholomatos, G. (2020) · Journal of Molecular Medicine · doi:10.1007/s00109-020-01891-1 · Cited by 8
Tumor suppressors in acute myeloid leukemia
Wallwitz, J., Aigner, P., & Stoiber, D. (2021) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2021.1907372 · Cited by 9
Splicing regulation in hematopoiesis
Chen, S., & Abdel-Wahab, O. I. (2021) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000661 · Cited by 9
Apolipoprotein A1 as a novel urinary biomarker for diagnosis of bladder cancer
Dardeer, K. T., Mohammed, K. A., Hussein, T. D., & ElSheemy, M. S. (2021) · Indian Journal of Urology · doi:10.4103/iju.iju_69_21 · Cited by 8
Molecular study of Nucleophosmin 1(NPM1) gene in acute myeloid leukemia in Kurdish population
Othman, G. O., Mohammad, N. S., & Saeed, C. H. (2021) · African Health Sciences · doi:10.4314/ahs.v21i2.26 · Cited by 8
Latest Contributions of Genomics to T-Cell Acute Lymphoblastic Leukemia (T-ALL)
Genescà, E., & González‐Gil, C. (2022) · Cancers · doi:10.3390/cancers14102474 · Cited by 8
Angelakis, A., Soulioti, I., & Filippakis, M. Ε. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e20530 · Cited by 8
Age-related clonal hematopoiesis: implications for hematopoietic stem cell transplantation
Abelson, S., & Wang, J. C. Y. (2018) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000465 · Cited by 8
Evidence of Clonal Hematopoiesis and Risk of Heart Failure
Bazeley, P. S., Morales, R., & Tang, W. H. W. (2020) · Current Heart Failure Reports · doi:10.1007/s11897-020-00476-w · Cited by 8
Dangerous Liaisons between Tet2 Mutation, Inflammatory Monocytes, and Leukemogenesis
Pietras, E. M., & DeGregori, J. V. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-22-0846 · Cited by 8
Köhrer, S., Dittrich, T., Schorb, M., Weinhold, N., Haberbosch, I., Börmel, M., Pajor, G., Goldschmidt, H., Müller‐Tidow, C., Raab, M. S., et al. (2023) · Leukemia · doi:10.1038/s41375-023-02056-y · Cited by 9
Lao, Z., Ding, L., Sun, Q.-Y., Li, J., Yan, B., Ng, A. Y. J., Capinpin, S. M., Wang, R., Li, Y., Chng, W. J., et al. (2024) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-22-3804 · Cited by 7
Clonal hematopoiesis, cardiovascular disease and cancer treatment-induced cardiotoxicity
Zhang, N., Tian, X., Sun, D.-K., Tse, G., Xie, B., Zhao, Z., & Liu, T. (2025) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2025.02.007 · Cited by 7
The pathogenesis of therapy-related myeloid neoplasms from TP53-mutant clonal hematopoiesis
Fullin, J., Topçu, E., Zielińska, K. A., Schimmer, R. R., Klemm, N., Koch, C., Caiado, F., Lock, M., Doerdelmann, C., Bühler, M. M., et al. (2025) · Leukemia · doi:10.1038/s41375-025-02839-5 · Cited by 9
Asxl1 deletion disrupts MYC and RNA polymerase II function in granulocyte progenitors
Braun, T. P., Estabrook, J., Schonrock, Z., Curtiss, B. M., Darmusey, L., Macaraeg, J., Enright, T., Coblentz, C., Callahan, R. L., Yashar, W. M., et al. (2022) · Leukemia · doi:10.1038/s41375-022-01792-x · Cited by 7
Metadata
- Authors
- Abelson, S., Collord, G., Ng, S. W. K., Weissbrod, O., Mendelson Cohen, N., Niemeyer, E., Barda, N., Zuzarte, P. C., Heisler, L., Sundaravadanam, Y., Luben, R., Hayat, S., Wang, T. T., Zhao, Z., Cirlan, I., Pugh, T. J., Soave, D., Ng, K., Latimer, C., Hardy, C., Raine, K., Jones, D., Hoult, D., Britten, A., McPherson, J. D., Johansson, M., Mbabaali, F., Eagles, J., Miller, J. K., Pasternack, D., Timms, L., Krzyzanowski, P., Awadalla, P., Costa, R., Segal, E., Bratman, S. V., Beer, P., Behjati, S., Martincorena, I., Wang, J. C. Y., Bowles, K. M., Quirós, J. R., Karakatsani, A., La Vecchia, C., Trichopoulou, A., Salamanca-Fernández, E., Huerta, J. M., Barricarte, A., Travis, R. C., Tumino, R., Masala, G., Boeing, H., Panico, S., Kaaks, R., Krämer, A., Sieri, S., Riboli, E., Vineis, P., Foll, M., McKay, J., Polidoro, S., Sala, N., Khaw, K.-T., Vermeulen, R., Campbell, P. J., Papaemmanuil, E., Minden, M. D., Tanay, A., Balicer, R. D., Wareham, N. J., Gerstung, M., Dick, J. E., Brennan, P., Vassiliou, G. S., & Shlush, L. I.
- Affiliations
- University Health Network (CA)
- University of Cambridge (GB)
- University of Toronto (CA)
- Weizmann Institute of Science (IL)
- Clalit Health Services (IL)
- Ontario Institute for Cancer Research (CA)
- Wellcome Sanger Institute (GB)
- Centre international de recherche sur le cancer (FR)
- European Bioinformatics Institute (GB)
- University of East Anglia (GB)
- Gobierno del Principado de Asturias (ES)
- National and Kapodistrian University of Athens (GR)
- Hellenic Health Foundation (GR)
- Instituto Murciano de Investigación Biosanitaria (ES)
- Instituto de Salud Pública de Navarra (ES)
- University of Oxford (GB)
- Istituto per lo Studio e la Prevenzione Oncologica (IT)
- German Institute of Human Nutrition (DE)
- Federico II University Hospital (IT)
- German Cancer Research Center (DE)
- Fondazione IRCCS Istituto Nazionale dei Tumori (IT)
- Imperial College London (GB)
- Italian institute for Genomic Medicine (IT)
- Institut d'Investigació Biomédica de Bellvitge (ES)
- Utrecht University (NL)
- Memorial Sloan Kettering Cancer Center (US)
- World Health Organization (CH)
- Wellcome/MRC Cambridge Stem Cell Institute (GB)
- Corresponding author
- Gerstung, Moritz
- Dick, John E.
- Brennan, Paul
- Vassiliou, George S.
- Shlush, Liran I.
- ORCID
- Abelson, Sagi
- Collord, Grace
- Ng, Stanley W. K.
- Weissbrod, Omer
- Barda, Noam
- Zuzarte, Philip C.
- Heisler, Lawrence
- Sundaravadanam, Yogi
- Luben, Robert
- Hayat, Shabina
- Zhao, Zhen
- Cirlan, Iulia
- Pugh, Trevor J.
- Soave, David
- Ng, Karen
- Latimer, Calli
- Raine, Keiran
- Jones, David
- Britten, Abigail
- McPherson, John D.
- Johansson, Mattias
- Eagles, Jenna
- Miller, Jessica K.
- Krzyzanowski, Paul
- Awadalla, Philip
- Costa, Rui
- Segal, Eran
- Bratman, Scott V.
- Beer, Philip
- Behjati, Sam
- Wang, Jean C. Y.
- Bowles, Kristian M.
- Karakatsani, Anna
- Trichopoulou, Antonia
- Huerta, José M.
- Barricarte, Aurelio
- Travis, Ruth C.
- Tumino, Rosario
- Masala, Giovanna
- Boeing, Heiner
- Panico, Salvatore
- Kaaks, Rudolf
- Krämer, Alwin
- Sieri, Sabina
- Vineis, Paolo
- Foll, Matthieu
- McKay, James
- Polidoro, Silvia
- Sala, Núria
- Khaw, Kay-Tee
- Vermeulen, Roel
- Campbell, Peter J.
- Papaemmanuil, Elli
- Minden, Mark D.
- Tanay, Amos
- Balicer, Ran D.
- Wareham, Nicholas J.
- Gerstung, Moritz
- Dick, John E.
- Brennan, Paul
- Vassiliou, George S.
- Shlush, Liran I.
- Venue
- Nature
- Published
- 2018-07
- Volume
- 559
- Issue
- 7714
- Pages
- 400-404
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC6485381
- OpenAlex
- W2830196912
- Cited by
- 850
- References
- 49
- Citations by year
- 2026: 52 · 2025: 83 · 2024: 95 · 2023: 116 · 2022: 122 · 2021: 116 · 2020: 143 · 2019: 91 · 2018: 29
- FWCI
- 67.70
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RISalud Institutional Health Repository of Andalucía (submittedVersion, public-domain)
- HAL (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) (submittedVersion, public-domain)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- eScholarship (California Digital Library) (submittedVersion)
- Spiral (Imperial College London) (submittedVersion)
- Apollo (University of Cambridge) (submittedVersion)
- Utrecht University Repository (Utrecht University) (submittedVersion)
- Apollo
- Funders
- World Health Organization
- Leukemia and Lymphoma Society
- Wellcome Trust (WT 098051, WT095663MA)
- Cancer Research UK (23015, 14136, 16491, 21777)
- National Institute for Health and Care Research (NF-SI-0512-10114, NF-SI-0512-10135, NF-SI-0617-10149)
- Generalitat de Catalunya
- Associazione Italiana per la Ricerca sul Cancro
- Clalit Health Services
- Abisch-Frenkel-Stiftung
- Hellenic Health Foundation
- Medical Research Council (MC_UU_12015/1, MC_PC_13048, MC_PC_12009, MR/N003284/1)
- Agència de Gestió d'Ajuts Universitaris i de Recerca
- Instituto de Salud Carlos III (RD12/0036/0018)
- European Regional Development Fund
- National Cancer Institute (P30CA008748)
- Topics
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
- Keywords
- acute myeloid leukemia, somatic mutations, clonal expansion, variant allele frequency
- MeSH terms
- Adult, Age Factors, Aged, Female, Health, Humans, Male, Middle Aged, Models, Genetic, Mutation, Leukemia, Myeloid, Acute, Prevalence, Mutagenesis, Disease Progression, Risk Assessment, Genetic Predisposition to Disease, Electronic Health Records
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
